Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Aura Biosciences (AURA) Return on Capital Employed (2021 - 2026)

Aura Biosciences filings provide 6 years of Return on Capital Employed readings, the most recent being 20.54% for Q1 2026.

  • Quarterly Return on Capital Employed fell 463.0% to 20.54% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 20.54% through Mar 2026, down 463.0% year-over-year, with the annual reading at 14.14% for FY2025, 520.0% down from the prior year.
  • Return on Capital Employed hit 20.54% in Q1 2026 for Aura Biosciences, down from 13.81% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 10.18% in Q4 2024 and bottomed at 47.23% in Q3 2024.
  • Average Return on Capital Employed over 5 years is 30.73%, with a median of 34.84% recorded in 2022.
  • The largest annual shift saw Return on Capital Employed tumbled -661bps in 2023 before it soared 3126bps in 2024.
  • Aura Biosciences' Return on Capital Employed stood at 34.84% in 2022, then fell by -19bps to 41.45% in 2023, then soared by 75bps to 10.18% in 2024, then crashed by -36bps to 13.81% in 2025, then plummeted by -49bps to 20.54% in 2026.
  • Per Business Quant, the three most recent readings for AURA's Return on Capital Employed are 20.54% (Q1 2026), 13.81% (Q4 2025), and 19.89% (Q3 2025).